Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gorka

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1990
The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigenG N Milligan, L A Morrison, J Gorka, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2024
Light-induced H<sub>2</sub> generation in a photosystem I-O<sub>2</sub>-tolerant [FeFe] hydrogenase nanoconstructTristen D Rumbaugh, Michael J Gorka, Carol S Baker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1995
Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modulesH Molina, S J Perkins, J Guthridge, et al.
Human Immunology|March 1, 1996
Indirect allorecognition of HLA class I peptides by CD4+ cytolytic T lymphocytesB Susskind, M R Iannotti, M D Shornick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1994
Peptide binding to surface class II molecules is the major pathway of formation of immunogenic class II-peptide complexes for viable antigen presenting cellsN R Nygard, K S Giacoletto, C Bono, et al.
The Journal of Biological Chemistry|July 5, 1991
Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interactionH Molina, C Brenner, S Jacobi, et al.
The Journal of Biological Chemistry|June 30, 1995
High affinity Ca(2+)-binding site in the serine protease domain of human factor VIIa and its role in tissue factor binding and development of catalytic activityA K Sabharwal, J J Birktoft, J Gorka, et al.
Nature|March 29, 1990
Peptide ligand-induced conformation and surface expression of the Ld class I MHC moleculeW R Lie, N B Myers, J Gorka, et al.
The Journal of Experimental Medicine|January 1, 1992
Disparate interaction of peptide ligand with nascent versus mature class I major histocompatibility complex molecules: comparisons of peptide binding to alternative forms of Ld in cell lysates and the cell surfaceJ D Smith, W R Lie, J Gorka, et al.
The Journal of Experimental Medicine|February 1, 1991
The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structureW R Lie, N B Myers, J M Connolly, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1990
The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigenG N Milligan, L A Morrison, J Gorka, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2024
Light-induced H<sub>2</sub> generation in a photosystem I-O<sub>2</sub>-tolerant [FeFe] hydrogenase nanoconstructTristen D Rumbaugh, Michael J Gorka, Carol S Baker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1995
Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modulesH Molina, S J Perkins, J Guthridge, et al.
Human Immunology|March 1, 1996
Indirect allorecognition of HLA class I peptides by CD4+ cytolytic T lymphocytesB Susskind, M R Iannotti, M D Shornick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1994
Peptide binding to surface class II molecules is the major pathway of formation of immunogenic class II-peptide complexes for viable antigen presenting cellsN R Nygard, K S Giacoletto, C Bono, et al.
The Journal of Biological Chemistry|July 5, 1991
Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interactionH Molina, C Brenner, S Jacobi, et al.
The Journal of Biological Chemistry|June 30, 1995
High affinity Ca(2+)-binding site in the serine protease domain of human factor VIIa and its role in tissue factor binding and development of catalytic activityA K Sabharwal, J J Birktoft, J Gorka, et al.
Nature|March 29, 1990
Peptide ligand-induced conformation and surface expression of the Ld class I MHC moleculeW R Lie, N B Myers, J Gorka, et al.
The Journal of Experimental Medicine|January 1, 1992
Disparate interaction of peptide ligand with nascent versus mature class I major histocompatibility complex molecules: comparisons of peptide binding to alternative forms of Ld in cell lysates and the cell surfaceJ D Smith, W R Lie, J Gorka, et al.
The Journal of Experimental Medicine|February 1, 1991
The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structureW R Lie, N B Myers, J M Connolly, et al.
Pageof 3